Dr. Alexander Zehnder

Dr. Alexander Zehnder joined CureVac as Chief Executive Officer in April 2023. Dr. Zehnder has held roles of increasing complexity and responsibility in the pharmaceutical industry for more than 20 years across multiple business units and functional areas in Europe, the United States, and Japan. He has a track record of building pipelines, developing strategies, shaping organizations, and delivering results.

Prior to CureVac, Dr. Zehnder was Global Head of Oncology at Sanofi and held country leadership positions at both headquarter and country levels. He was also a member of the oncology leadership team at Roche/Genentech, serving as Vice President, Global Product Strategy, and Global Franchise Head for Avastin®, the company’s blockbuster oncology drug.

Dr. Zehnder earned his MD from the University of Bern, Switzerland, and received his MBA at IMD Business School in Lausanne, Switzerland.